2024-2032 Report on Global Biopharmaceutical CMO & CRO Market by Player, Region, Type, Application and Sales Channel
Report Code: KNJ1769800 No. of Pages: 123 Category: Pharmaceuticals and Healthcare
Publisher: Date of Publish:
Publisher: Date of Publish:
The global Biopharmaceutical CMO & CRO market size is estimated to be $xx million in 2023, and MAResearch analysts predict it will reach $xx million by 2032, growing at a CAGR of xx% during the forecast period from 2024 to 2032.
This report studies the Biopharmaceutical CMO & CRO market, covering market size for segment by type (Contract Manufacturing, Contract Research, etc.), by application (Biologics, Biosimilars, etc.), by sales channel (Direct Channel, Distribution Channel), by player (Boehringer Ingelheim, Lonza, Inno Biologics, Rentschler Biotechnologie, JRS PHARMA, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa).
This report provides detailed historical analysis of global market for Biopharmaceutical CMO & CRO from 2018-2023, and provides extensive market forecasts from 2024-2032 by region/country and subsectors. It covers the sales/revenue/value, gross margin, historical growth and future perspectives in the Biopharmaceutical CMO & CRO market.
Leading Players of Biopharmaceutical CMO & CRO including:
Boehringer Ingelheim
Lonza
Inno Biologics
Rentschler Biotechnologie
JRS PHARMA
BIOMEVA
ProBioGen
FUJIFILM Diosynth Biotechnologies
TOYOBO
Samsung BioLogics
Thermo Fisher Scientific (Patheon)
AGC Biologics (CMC Biologics)
Binex
WuXi Biologics
AbbVie
Charles River Laboratories
ICON plc
Pharmaceutical Product Development
Laboratory Corporation of America Holdings
PAREXEL International Corporation
PRA Health Sciences
GenScript
IDTDNA
Eufin
TWIST
ABCam
BioRab
GeneWiz
Market split by Type:
Contract Manufacturing
Contract Research
Market split by Application:
Biologics
Biosimilars
Market split by Sales Channel:
Direct Channel
Distribution Channel
Market split by Region/Country:
North America (United States and Canada)
Europe (Germany, UK, France, Italy, Spain, and Russia, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, and Southeast Asia, etc.)
South America (Brazil, Mexico, and Argentina, etc.)
Middle East & Africa (Turkey, UAE, Saudi Arabia, and South Africa, etc.)
If you have any special requirements, please let us know and we can provide you the customized report as you want.
Table of Contents
Chapter 1 Biopharmaceutical CMO & CRO Market Overview
1.1 Biopharmaceutical CMO & CRO Definition
1.2 Global Biopharmaceutical CMO & CRO Market Size Status and Outlook (2018-2032)
1.3 Global Biopharmaceutical CMO & CRO Market Size Comparison by Region (2018-2032)
1.4 Global Biopharmaceutical CMO & CRO Market Size Comparison by Type (2018-2032)
1.5 Global Biopharmaceutical CMO & CRO Market Size Comparison by Application (2018-2032)
1.6 Global Biopharmaceutical CMO & CRO Market Size Comparison by Sales Channel (2018-2032)
1.7 Biopharmaceutical CMO & CRO Market Dynamics
1.7.1 Market Drivers/Opportunities
1.7.2 Market Challenges/Risks
1.7.3 Market News (Merger/Acquisition/Expansion)
1.7.4 Key Trends in Biopharmaceutical CMO & CRO Market
Chapter 2 Biopharmaceutical CMO & CRO Market Competition by Player
2.1 Global Biopharmaceutical CMO & CRO Sales and Market Share by Player (2021-2023)
2.2 Global Biopharmaceutical CMO & CRO Revenue and Market Share by Player (2021-2023)
2.3 Global Biopharmaceutical CMO & CRO Average Price by Player (2021-2023)
2.4 Players Competition Situation & Trends
2.5 Conclusion of Segment by Player
Chapter 3 Biopharmaceutical CMO & CRO Market Segment by Type
3.1 Global Biopharmaceutical CMO & CRO Market by Type
3.1.1 Contract Manufacturing
3.1.2 Contract Research
3.2 Global Biopharmaceutical CMO & CRO Sales and Market Share by Type (2018-2023)
3.3 Global Biopharmaceutical CMO & CRO Revenue and Market Share by Type (2018-2023)
3.4 Global Biopharmaceutical CMO & CRO Average Price by Type (2018-2023)
3.5 Conclusion of Segment by Type
Chapter 4 Biopharmaceutical CMO & CRO Market Segment by Application
4.1 Global Biopharmaceutical CMO & CRO Market by Application
4.1.1 Biologics
4.1.2 Biosimilars
4.2 Global Biopharmaceutical CMO & CRO Revenue and Market Share by Application (2018-2023)
4.3 Conclusion of Segment by Application
Chapter 5 Biopharmaceutical CMO & CRO Market Segment by Sales Channel
5.1 Global Biopharmaceutical CMO & CRO Market by Sales Channel
5.1.1 Direct Channel
5.1.2 Distribution Channel
5.2 Global Biopharmaceutical CMO & CRO Revenue and Market Share by Sales Channel (2018-2023)
5.3 Conclusion of Segment by Sales Channel
Chapter 6 Biopharmaceutical CMO & CRO Market Segment by Region & Country
6.1 Global Biopharmaceutical CMO & CRO Market Size and CAGR by Region (2018-2032)
6.2 Global Biopharmaceutical CMO & CRO Sales and Market Share by Region (2018-2023)
6.3 Global Biopharmaceutical CMO & CRO Revenue and Market Share by Region (2018-2023)
6.4 North America
6.4.1 North America Market by Country
6.4.2 North America Biopharmaceutical CMO & CRO Market Share by Type
6.4.3 North America Biopharmaceutical CMO & CRO Market Share by Application
6.4.4 United States
6.4.5 Canada
6.5 Europe
6.5.1 Europe Market by Country
6.5.2 Europe Biopharmaceutical CMO & CRO Market Share by Type
6.5.3 Europe Biopharmaceutical CMO & CRO Market Share by Application
6.5.4 Germany
6.5.5 UK
6.5.6 France
6.5.7 Italy
6.5.8 Spain
6.5.9 Russia
6.6 Asia-Pacific
6.6.1 Asia-Pacific Market by Country
6.6.2 Asia-Pacific Biopharmaceutical CMO & CRO Market Share by Type
6.6.3 Asia-Pacific Biopharmaceutical CMO & CRO Market Share by Application
6.6.4 China
6.6.5 Japan
6.6.6 Korea
6.6.7 India
6.6.8 Southeast Asia
6.6.9 Australia
6.7 South America
6.7.1 South America Market by Country
6.7.2 South America Biopharmaceutical CMO & CRO Market Share by Type
6.7.3 South America Biopharmaceutical CMO & CRO Market Share by Application
6.7.4 Brazil
6.7.5 Mexico
6.7.6 Argentina
6.7.7 Colombia
6.8 Middle East & Africa
6.8.1 Middle East & Africa Market by Country
6.8.2 Middle East & Africa Biopharmaceutical CMO & CRO Market Share by Type
6.8.3 Middle East & Africa Biopharmaceutical CMO & CRO Market Share by Application
6.8.4 Turkey
6.8.5 UAE
6.8.6 Saudi Arabia
6.8.7 South Africa
6.9 Conclusion of Segment by Region
Chapter 7 Profile of Leading Biopharmaceutical CMO & CRO Players
7.1 Boehringer Ingelheim
7.1.1 Company Snapshot
7.1.2 Product/Service Offered
7.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
7.2 Lonza
7.3 Inno Biologics
7.4 Rentschler Biotechnologie
7.5 JRS PHARMA
7.6 BIOMEVA
7.7 ProBioGen
7.8 FUJIFILM Diosynth Biotechnologies
7.9 TOYOBO
7.10 Samsung BioLogics
7.11 Thermo Fisher Scientific (Patheon)
7.12 AGC Biologics (CMC Biologics)
7.13 Binex
7.14 WuXi Biologics
7.15 AbbVie
7.16 Charles River Laboratories
7.17 ICON plc
7.18 Pharmaceutical Product Development
7.19 Laboratory Corporation of America Holdings
7.20 PAREXEL International Corporation
7.21 PRA Health Sciences
7.22 GenScript
7.23 IDTDNA
7.24 Eufin
7.25 TWIST
7.26 ABCam
7.27 BioRab
7.28 GeneWiz
Chapter 8 Upstream and Downstream Analysis of Biopharmaceutical CMO & CRO
8.1 Industrial Chain of Biopharmaceutical CMO & CRO
8.2 Upstream of Biopharmaceutical CMO & CRO
8.3 Downstream of Biopharmaceutical CMO & CRO
Chapter 9 Development Trend of Biopharmaceutical CMO & CRO (2024-2032)
9.1 Global Biopharmaceutical CMO & CRO Market Size (Sales and Revenue) Forecast (2024-2032)
9.2 Global Biopharmaceutical CMO & CRO Market Size and CAGR Forecast by Region (2024-2032)
9.3 Global Biopharmaceutical CMO & CRO Market Size and CAGR Forecast by Type (2024-2032)
9.4 Global Biopharmaceutical CMO & CRO Market Size and CAGR Forecast by Application (2024-2032)
9.5 Global Biopharmaceutical CMO & CRO Market Size and CAGR Forecast by Sales Channel (2024-2032)
Chapter 10 Appendix
10.1 Research Methodology
10.2 Data Sources
10.3 Disclaimer
10.4 Analysts Certification
NEED Help?
If you need any help or guidance, please feel free to call us.
USA : +1 (661) 636 6162
INDIA : +91 9325802062
or
Write us on : sales@kandjmarketresearch.com